Skip to content

Screener

Eligibility screening

Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

Sponsored by MOMA TherapeuticsStudy detailsClinicalTrials.gov

8 US sites in CA, FL, MI, MO +3

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.